CAB39 抗体
Quick Overview for CAB39 抗体 (ABIN6242214)
抗原
See all CAB39 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
- 
    - 
                                            预测反应
- B
- 
                                            纯化方法
- This antibody is purified through a protein G column, followed by dialysis against PBS.
- 
                                            免疫原
- This CAB39 monoclonal antibody is generated from mouse immunized with CAB39 recombinant protein.
- 
                                            亚型
- IgG1 kappa
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- WB: 1:1000
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            缓冲液
- Purified monoclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
- 
                                            储存液
- Sodium azide
- 
                                            注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            储存条件
- 4 °C,-20 °C
- 
                                            有效期
- 6 months
 
- 
                                            
- 
    - CAB39 (Calcium Binding Protein 39 (CAB39))
- 
                                            别名
- CAB39
- 
                                            背景
- Together with the STE20-related adaptor-alpha (STRAD alpha) pseudo kinase, forms a regulatory complex capable of stimulating the activity of STK11.
- 
                                            分子量
- 39869
- 
                                            NCBI登录号
- NP_001124321, NP_001124322, NP_057373
- 
                                            UniProt
- Q9Y376
- 
                                            途径
- AMPK Signaling
 抗原
- 
                    
 
                                     
                                     
                                    